These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 36581860)
21. Clear cell variant of diffuse large B-cell lymphoma: a case report and review of the literature. Xue Y; Wang Q; He X Int J Clin Exp Pathol; 2015; 8(6):7594-9. PubMed ID: 26261675 [TBL] [Abstract][Full Text] [Related]
22. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy]. Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050 [TBL] [Abstract][Full Text] [Related]
23. Primary central nervous system lymphoma: a clinicopathological study of 75 cases. Preusser M; Woehrer A; Koperek O; Rottenfusser A; Dieckmann K; Gatterbauer B; Roessler K; Slavc I; Jaeger U; Streubel B; Hainfellner JA; Chott A Pathology; 2010; 42(6):547-52. PubMed ID: 20854073 [TBL] [Abstract][Full Text] [Related]
24. Primary Central Nervous System T-Cell Lymphoma With Aberrant Expression of CD20 and CD79a: A Diagnostic Pitfall. Gupta N; Nasim M; Spitzer SG; Zhang X Int J Surg Pathol; 2017 Oct; 25(7):599-603. PubMed ID: 28612664 [TBL] [Abstract][Full Text] [Related]
25. CD20-negative primary middle ear diffuse large B-cell lymphoma coexpressing MYC and BCL-2 secondary to acute lymphoblastic leukemia: A case report. Ding C; Huang Y; Shi M; Nie B; Li Y; Wu K; Yang J; Zeng Y Medicine (Baltimore); 2019 Apr; 98(15):e15204. PubMed ID: 30985716 [TBL] [Abstract][Full Text] [Related]
26. [Primary central nervous system diffuse large B cell lymphoma: a clinicopathologic and molecular study]. Ma ZP; Ainiwaer B; Liu ZY; Shi XL; Cui WL; Zhang W; Li XX Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):762-768. PubMed ID: 27821230 [No Abstract] [Full Text] [Related]
27. Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse. Villa D; Connors JM; Sehn LH; Gascoyne RD; Savage KJ Haematologica; 2011 Jul; 96(7):1002-7. PubMed ID: 21486867 [TBL] [Abstract][Full Text] [Related]
28. A cyclin D1-positive diffuse large B-cell lymphoma of germinal center B-cell-like subtype in the right tonsil: A rare case report. Jiang C; Shi X; Fan C Medicine (Baltimore); 2017 Mar; 96(11):e6311. PubMed ID: 28296741 [TBL] [Abstract][Full Text] [Related]
29. Cerebellar large B-cell lymphoma: a case report. Ghannam M; Mansour S; Jumah F; Berry B; Beard A J Med Case Rep; 2018 Nov; 12(1):341. PubMed ID: 30446015 [TBL] [Abstract][Full Text] [Related]
30. [Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases]. Yang H; Lang RG; Liu FF; Wang XF; Jin ZJ; Lü AJ; Wang Y; Fu XL; Fu L Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):79-84. PubMed ID: 21426801 [TBL] [Abstract][Full Text] [Related]
31. Primary large B-cell lymphoma of the central nervous system with positive NMDAR antibody: a case report. Li X; Sun M; Liu W; Liu N; Yuan B; Su X BMC Neurol; 2022 Aug; 22(1):298. PubMed ID: 35962342 [TBL] [Abstract][Full Text] [Related]
32. Laryngeal Diffuse Large B-Cell Lymphoma Presenting as Laryngeal Stenosis. Tang Y; Li P; Cua D; Lai J In Vivo; 2020; 34(1):255-260. PubMed ID: 31882486 [TBL] [Abstract][Full Text] [Related]
33. Primary renal diffuse large B-cell lymphoma with central nervous system involvement: a rare case report and literature review. Wang Y; Guo S Int J Clin Exp Pathol; 2015; 8(6):7045-9. PubMed ID: 26261597 [TBL] [Abstract][Full Text] [Related]
34. Secondary Central Nerve System Lymphoma With Intratumoral Hemorrhage Suggested as Intravascular Lymphoma by Autopsy: A Case Report. Suzuki Y; Tanaka H; Suyama K; Mochida H; Suzuki Y J Clin Med Res; 2017 Nov; 9(11):953-957. PubMed ID: 29038675 [TBL] [Abstract][Full Text] [Related]
35. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]
36. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas. Bhagavathi S; Sharathkumar A; Hunter S; Sung L; Kanhere R; Venturina MD; Wilson JD Clin Neuropathol; 2008; 27(1):13-20. PubMed ID: 18257470 [TBL] [Abstract][Full Text] [Related]